University of Oxford - Nuffield Department of Medicine, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Harvard University - Division of Population Sciences, Harvard University - Massachusetts General Hospital, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Massachusetts General Hospital, Government of the United States of America - Frederick National Laboratory for Cancer Research, EMD Serono Research & Development Institute - Bioinformatics, Department of Translational Medicine, Harvard University - Dana-Farber Cancer Institute, Bristol Myers Squibb, Pfizer, Inc. - Computational Biology, Pfizer, Inc. - Translational Oncology, Harvard University - Division of Population Sciences, Harvard University - Lank Center for Genitourinary Oncology, National Institutes of Health (NIH) - Clinical Immunotherapy Section and National Cancer Institute - Basic Science Program

Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Mount Sinai Health System - Division of Hematology and Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Urologic Surgery, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Medical Oncology, Harvard University - Melanoma Center, Harvard University - Department of Pathology, Harvard University - Department of Data Science, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Genetics and Harvard University - Division of Population Sciences

Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard Medical School - Division of Pulmonary and Critical Care Medicine and Genetics, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Invitae Corporation, InVitae Corporation, Invitae Corporation, InVitae Corporation, InVitae Corporation, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute - Division of Population Sciences, Harvard University - Division of Population Sciences and Harvard University - Lank Center for Genitourinary Oncology